Post-liver transplantation GVHD: time to consider histocompatibility testing - 23/12/21
Abstract |
The development of Graft-Versus-Host Disease (GVHD) post-liver transplantation (LT) is an uncommon complication. GVHD occurs when immunocompetent donor lymphocytes originating from the transplanted liver mount a destructive immune response against the immunocompromised recipient. Diagnosis of post-LT GVHD represents a major challenge due to lack of standard criteria a rarity of the condition. Therefore, diagnosis and initiation of therapy are often delayed.
Here, we report a case of a one-year old child who developed GVHD two months post-LT. A full investigation with histocompatibility testing was performed post-LT demonstrated many risk factors of developing post-LT GVHD. The chimerism analysis showed 39% mixed chimerism in the recipient's peripheral blood. The mother was homozygous donor with broad sensitization against the patient's mismatched antigens. Reverse flow crossmatch exhibited strong positive T and B cells crossmatches. This case was missed because unlike other solid organ transplants, routine histocompatibility testing is not often required before liver transplantation.
In conclusion, although post-LT GVHD is a rare complication, proper histocompatibility testing prior LT is critical to prevent post-LT GVHD incidence. Additionally, it can be useful as a diagnostic tool post-LT to exclude competing etiology and begin treatment regimen.
Le texte complet de cet article est disponible en PDF.Mots-clés : GVHD, liver transplantation, pediatrics, histocompatibility, HLA, antibodies, human leukocyte antigen
Abbreviations : FCXM, GVHD, HLA, LT, MFI, POD
Plan
Authorship statement: The author, Salim S. Ghandorah, made a substantive intellectual contribution in designing, preparing and writing of this manuscript. The author followed up the patient and ensured requesting, arranging, preparing samples and experiments, and interpretation of data. Dr. Kholoud Alwosaibai significantly contributed in this work by critically evaluating and reviewing the paper. Both authors contributed in conducting a comprehensive literature review. |
|
Disclosure: The authors declare no conflicts of interest. |
|
Funding: None. |
Vol 3
Article 100021- juillet 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.